UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019614
Receipt number R000022372
Scientific Title Research on the pathogenesis of autosomal dominant polycystic kidney disease
Date of disclosure of the study information 2015/11/02
Last modified on 2021/05/07 11:12:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on the pathogenesis of autosomal dominant polycystic kidney disease

Acronym

ADPKD-Hokkaido-1

Scientific Title

Research on the pathogenesis of autosomal dominant polycystic kidney disease

Scientific Title:Acronym

ADPKD-Hokkaido-1

Region

Japan


Condition

Condition

Autosomal dominant polycystic kidney disease

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To explore prognostic factors in Japanese patients with ADPKD based on information in electronic medical charts and genetic information collected from patients with ADPKD who have visited or been admitted to Hokkaido University Hospital or its related hospitals

Basic objectives2

Others

Basic objectives -Others

Risk factors for increase in kidney volume, which is considered a surrogate marker of reduction in renal function, as well as complications such as cerebral aneurysm, will be explored

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Evaluation of factors that may affect the progression of ADPKD (annual percentage change in kidney volume)

Key secondary outcomes

Evaluation of factors that may affect the progression of ADPKD (annual change in eGFR)
Exploration of factors that may affect the onset of ADPKD-related events (cerebral aneurysm, hypertension, urolithiasis, renal pain, macroscopic hematuria, cyst infection, urinary tract infection, proteinuria, dialysis, and other ADPKD-related events) and other major events (e.g., cardiovascular events)
Comparison of genetic background information between subjects and healthy adults


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with a diagnosis of ADPKD who have visited or been admitted to Hokkaido University Hospital or its related hospitals at least twice
Patients who meet the following criterion if blood and/or urine samples will be collected:
- Patients who are capable to consent

Key exclusion criteria

Patients who meet the following criterion if blood and/or urine samples will be collected:
- Patients who, in the opinion of the investigator, are inappropriate for the study

Target sample size

250


Research contact person

Name of lead principal investigator

1st name Saori
Middle name
Last name Nishio

Organization

Hokkaido University School of Medicine

Division name

Department of Medicine II

Zip code

060-8648

Address

Kita 14, Nishi 5, Kita-ku, Sapporo, Japan

TEL

011-706-5915

Email

saorin@med.hokudai.ac.jp


Public contact

Name of contact person

1st name Saori
Middle name
Last name Nishio

Organization

Hokkaido University School of Medicine

Division name

Department of Medicine II

Zip code

060-8648

Address

Kita 14, Nishi 5, Kita-ku, Sapporo, Japan

TEL

011-706-5915

Homepage URL


Email

saorin@med.hokudai.ac.jp


Sponsor or person

Institute

Otsuka Pharmaceutical Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Otsuka Pharmaceutical Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hokkaido University

Address

Kita 15, Nishi 7, Kita-ku, Sapporo, Japan

Tel

+81-11-706-5915

Email

saorin@med.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北海道大学病院(北海道)、北見赤十字病院(北海道)、旭川医科大学(北海道)


Other administrative information

Date of disclosure of the study information

2015 Year 11 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

255

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

We need time to analyze the data.

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2015 Year 10 Month 13 Day

Date of IRB

2015 Year 09 Month 29 Day

Anticipated trial start date

2015 Year 11 Month 10 Day

Last follow-up date

2016 Year 10 Month 31 Day

Date of closure to data entry

2018 Year 04 Month 30 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information

Evaluation of factors that may affect the progression of ADPKD (annual change in eGFR)
Exploration of factors that may affect the onset of ADPKD-related events (cerebral aneurysm, hypertension, urolithiasis, renal pain, macroscopic hematuria, cyst infection, urinary tract infection, proteinuria, dialysis, and other ADPKD-related events) and other major events (e.g., cardiovascular events)
Comparison of genetic background information between subjects and healthy adults


Management information

Registered date

2015 Year 11 Month 02 Day

Last modified on

2021 Year 05 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022372


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name